Rain Oncology Inc. Proceeds from Convertible Debt
Rain Oncology Inc. reported Proceeds from Convertible Debt of $0 for the 9-month period ending 2021-09-30, per its 10-Q filed 2021-11-10.
Discontinued › Cash Flow › Financing Activities
us-gaap:ProceedsFromConvertibleDebt · last filed 2022-03-03
- Rain Oncology Inc. proceeds from convertible debt for the quarter ending 2020-12-31 was $0.00.
- Rain Oncology Inc. proceeds from convertible debt for the quarter ending 2020-09-30 was $0.00.
- Rain Oncology Inc. proceeds from convertible debt for fiscal 2020 was $6.43M.
| Period end | Proceeds from Convertible Debt 3 month | Proceeds from Convertible Debt 6 month | Proceeds from Convertible Debt 9 month | Proceeds from Convertible Debt 12 month |
|---|---|---|---|---|
| 2021-09-30 | $0.00 10-Q · filed 2021-11-10 | |||
| 2020-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-03 | $0.00 derived: sum of 2 quarters · filed 2022-03-03 | $6.43M 10-K · filed 2022-03-03 | |
| 2020-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-10 | $6.43M 10-Q · filed 2021-11-10 | ||
| 2020-06-30 | $6.43M 10-Q · filed 2021-08-10 |